About our research interests
The Viral Immunology Group aims to understand the mechanisms by which pathogens target and evade molecular and cellular immune responses.
These early pipe-line immunological discoveries feed our translational research in the development of novel therapeutics, designed to restore effective immunity and thus eliminate these infectious agents.
Our research currently analyses the effects of Human Immunodeficiency Virus (HIV), Respiratory Syncytial Virus (RSV) and Hepatitis C Virus (HCV) upon functional responses of anti-viral and inflammatory cytokines.
We investigate intracellular signalling cascades, such as the JAK/STAT pathway and explore immune regulation via intracellular proteins, such as Suppressor of Cytokine Signalling (SOCS). Our translational research is carried out in the context of both in vitro infection models and primary human patient immune cells.
Science Gallery Events: Invited Viral Immunology Panel Expert
- Revisiting the rapid response to coronavirus
- THE GLOBAL RESPONSE TO HIV: 90-90-90 by 2020 – what does it mean and will we make it?